Table 4. Clinical Outcomes, Remission Rate and Survival.

Median survival, all patients (days)	1,095
Survived, initial hemophagocytic lymphohistiocytosis hospitalization	25 (61%)
Remission	21/25 (84%)
Died (due to any cause), following hospital discharge	7/25 (28%)
Median survival of those who died following hospital discharge (days)	240
Died, initial hemophagocytic lymphohistiocytosis hospitalization	16 (39%)
Sepsis or multi-organ failure	16/16 (100%)
Pneumonia and/or respiratory failure	7/16 (43.7%)
Malignancy-associated	6/16 (37.5%)
Medication-induced	1/16 (6%) Stevens-Johnson syndrome vs. toxic epidermal necrolysis